Hope With Answers: Liquid Biopsy

A new and exciting way to identify biomarkers, liquid biopsies are blood tests. In the past, some lung cancer patients could not take advantage of the latest discoveries in personalized medicine because there was not enough tissue to do biomarker testing. With FDA approval of the first liquid biopsy in 2016 and advances in research, specific genetic drivers, or suspected drivers, can be detected in more than half of lung cancers.

Hope With Answers Video Series: Liquid Biopsy

Dr. Greg Riely of Memorial Sloan Kettering Cancer Center discusses the basics of liquid biopsy for lung cancer with patient and advocate Lisa Goldman. Patient and advocate Lysa Buonanno discusses the most in-depth information surrounding liquid biopsy for lung cancer with Dr. Greg Riely of Memorial Sloan Kettering Cancer Center.

A lung cancer game changer

Less invasive with quicker results.

Not long ago, liquid biopsies were once the province of theory and hope. Now they are becoming part of the standard of care in lung cancer.

Living with
lung cancer

Dr. Christine Lovly - LCFA Grant award recipient

Dr. Lovly is using her LCFA research grant to study the ability of liquid biopsies to monitor small cell lung cancer in a better and more precise way.

Get informed. Stay informed.

Join our community.

Sign up for the Lung Cancer Foundation of America’s newsletter to stay up to date on how liquid biopsies are being used in lung cancer detection and treatment.